Giorgos Bamias1, Kristen O Arseneau, Fabio Cominelli. 1. aAcademic Department of Gastroenterology, Kapodistrian University of Athens, Laikon Hospital, Athens, Greece bDivision of Gastrointestinal and Liver Disease, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Abstract
PURPOSE OF REVIEW: Cytokines are integral mediators for maintaining intestinal mucosal homeostasis, as well as prominent effector molecules during chronic gut inflammatory diseases. This review focuses on recent studies of the role of specific cytokines in mucosal immunity. RECENT FINDINGS: Dichotomous, or even opposing, functions have been described for several cytokines involved in intestinal innate immunity (most notably for members of the interleukin-1 family), which depend on the specific inflammatory conditions within the intestinal mucosa. For example, both interleukin-1α and interleukin-33 exhibit 'alarmin'-type properties that can signal tissue or cell damage, which further add to their well described proinflammatory roles. Costimulatory molecules of the tumor necrosis factor/tumor necrosis factor receptor superfamily, such as TNF-like cytokine 1A and LIGHT, are actively involved in mucosal proinflammatory pathways, but also may exert protection against infectious agents to facilitate recovery from acute inflammation. Finally, innate lymphoid cells are increasingly recognized as important cellular sources of pivotal mucosal cytokines, including the interleukin-23/T helper 17 cytokine, interleukin-22. SUMMARY: Elucidating the complexity of cytokine signaling within the normal mucosa and during acute and chronic inflammation will be a pivotal step toward understanding the pathogenesis of immune-mediated gut diseases and developing effective therapies to treat them.
PURPOSE OF REVIEW: Cytokines are integral mediators for maintaining intestinal mucosal homeostasis, as well as prominent effector molecules during chronic gut inflammatory diseases. This review focuses on recent studies of the role of specific cytokines in mucosal immunity. RECENT FINDINGS: Dichotomous, or even opposing, functions have been described for several cytokines involved in intestinal innate immunity (most notably for members of the interleukin-1 family), which depend on the specific inflammatory conditions within the intestinal mucosa. For example, both interleukin-1α and interleukin-33 exhibit 'alarmin'-type properties that can signal tissue or cell damage, which further add to their well described proinflammatory roles. Costimulatory molecules of the tumor necrosis factor/tumor necrosis factor receptor superfamily, such as TNF-like cytokine 1A and LIGHT, are actively involved in mucosal proinflammatory pathways, but also may exert protection against infectious agents to facilitate recovery from acute inflammation. Finally, innate lymphoid cells are increasingly recognized as important cellular sources of pivotal mucosal cytokines, including the interleukin-23/T helper 17 cytokine, interleukin-22. SUMMARY: Elucidating the complexity of cytokine signaling within the normal mucosa and during acute and chronic inflammation will be a pivotal step toward understanding the pathogenesis of immune-mediated gut diseases and developing effective therapies to treat them.
Authors: S Kugathasan; L J Saubermann; L Smith; D Kou; J Itoh; D G Binion; A D Levine; R S Blumberg; C Fiocchi Journal: Gut Date: 2007-08-06 Impact factor: 23.059
Authors: Lisa A Mielke; Sarah A Jones; Mathilde Raverdeau; Rowan Higgs; Anna Stefanska; Joanna R Groom; Alicja Misiak; Lara S Dungan; Caroline E Sutton; Gundula Streubel; Adrian P Bracken; Kingston H G Mills Journal: J Exp Med Date: 2013-05-20 Impact factor: 14.307
Authors: F Meylan; E T Hawley; L Barron; J L Barlow; P Penumetcha; M Pelletier; G Sciumè; A C Richard; E T Hayes; J Gomez-Rodriguez; X Chen; W E Paul; T A Wynn; A N J McKenzie; R M Siegel Journal: Mucosal Immunol Date: 2013-12-25 Impact factor: 7.313
Authors: Jennifer A Fulcher; Laura Romas; Jennifer C Hoffman; Julie Elliott; Terry Saunders; Adam D Burgener; Peter A Anton; Otto O Yang Journal: AIDS Res Hum Retroviruses Date: 2017-06-19 Impact factor: 2.205
Authors: B Shannon; P Gajer; T J Yi; B Ma; M S Humphrys; J Thomas-Pavanel; L Chieza; P Janakiram; M Saunders; W Tharao; S Huibner; K Shahabi; J Ravel; R Kaul Journal: J Infect Dis Date: 2017-05-01 Impact factor: 5.226
Authors: Lisa Del Bel Belluz; Riccardo Guidi; Ioannis S Pateras; Laura Levi; Boris Mihaljevic; Syed Fazle Rouf; Marie Wrande; Marco Candela; Silvia Turroni; Claudia Nastasi; Clarissa Consolandi; Clelia Peano; Toma Tebaldi; Gabriella Viero; Vassilis G Gorgoulis; Thorbjørn Krejsgaard; Mikael Rhen; Teresa Frisan Journal: PLoS Pathog Date: 2016-04-07 Impact factor: 6.823